Roles of white matter in central nervous system pathophysiologies
暂无分享,去创建一个
[1] D. Pitt,et al. Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage , 2001, Annals of neurology.
[2] Thomas Möller,et al. Anaerobic Function of CNS White Matter Declines with Age , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] N. Uranova,et al. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium , 2004, Schizophrenia Research.
[4] J. Alix,et al. Glutamate receptor‐mediated ischemic injury of premyelinated central axons , 2009, Annals of neurology.
[5] W. Gan,et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides , 2006, Nature Neuroscience.
[6] Amaia M. Arranz,et al. P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis , 2007, The Journal of Neuroscience.
[7] M. Kukley,et al. Vesicular glutamate release from axons in white matter , 2007, Nature Neuroscience.
[8] Federico N. Soria,et al. Increased expression of cystine/glutamate antiporter in multiple sclerosis , 2011, Journal of Neuroinflammation.
[9] R. Douglas Fields,et al. Control of Local Protein Synthesis and Initial Events in Myelination by Action Potentials , 2011, Science.
[10] N. Maragakis,et al. Reduction in expression of the astrocyte glutamate transporter, GLT1, worsens functional and histological outcomes following traumatic spinal cord injury , 2011, Glia.
[11] A. Pérez-Samartín,et al. P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia , 2012, Neurobiology of Disease.
[12] L. Had‐Aissouni. Toward a new role for plasma membrane sodium-dependent glutamate transporters of astrocytes: maintenance of antioxidant defenses beyond extracellular glutamate clearance , 2011, Amino Acids.
[13] S. Skaper,et al. The P2X7 purinergic receptor: from physiology to neurological disorders , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] C. Brosnan,et al. Exacerbation of Experimental Autoimmune Encephalomyelitis in P2X7R−/− Mice: Evidence for Loss of Apoptotic Activity in Lymphocytes1 , 2006, The Journal of Immunology.
[15] Axons get excited to death , 2009, Annals of neurology.
[16] C. Reid,et al. The P2X7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X7R Pore , 2009, The Journal of Neuroscience.
[17] J. Ryu,et al. Amyloid beta peptide-induced corpus callosum damage and glial activation in vivo. , 2003, Neuroreport.
[18] C. Matute,et al. Caspase-Dependent and Caspase-Independent Oligodendrocyte Death Mediated by AMPA and Kainate Receptors , 2003, The Journal of Neuroscience.
[19] Hideyo Sato,et al. The oxidative stress-inducible cystine/glutamate antiporter, system xc−: cystine supplier and beyond , 2011, Amino Acids.
[20] W. Gan,et al. ATP mediates rapid microglial response to local brain injury in vivo , 2005, Nature Neuroscience.
[21] J. Ford,et al. Schizophrenia, myelination, and delayed corollary discharges: a hypothesis. , 2012, Schizophrenia bulletin.
[22] P. Stys,et al. Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. , 2010, Trends in molecular medicine.
[23] C. Matute,et al. Expression of glutamate transporters in rat optic nerve oligodendrocytes , 1999, The European journal of neuroscience.
[24] T. Montine,et al. White matter lesions defined by diffusion tensor imaging in older adults , 2011, Annals of neurology.
[25] M. Hediger,et al. Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate , 1996, Neuron.
[26] B. Trapp,et al. Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors , 2009, Annals of neurology.
[27] R. Cunha,et al. Presynaptic Modulation Controlling Neuronal Excitability and Epileptogenesis: Role of Kainate, Adenosine and Neuropeptide Y Receptors , 2003, Neurochemical Research.
[28] D. Attwell,et al. The role of pannexin hemichannels in the anoxic depolarization of hippocampal pyramidal cells , 2010, Brain : a journal of neurology.
[29] H. Kettenmann,et al. Purinergic signaling and microglia , 2006, Pflügers Archiv.
[30] A. Dolphin,et al. Vesicular apparatus, including functional calcium channels, are present in developing rodent optic nerve axons and are required for normal node of Ranvier formation , 2008, The Journal of physiology.
[31] F. Kirchhoff,et al. NMDA Receptors in Glia , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[32] W. Bowers,et al. Triple‐transgenic Alzheimer's disease mice exhibit region‐specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology , 2009, Glia.
[33] D. W. Desmond. Cognition and White Matter Lesions , 2002, Cerebrovascular Diseases.
[34] Amaia M. Arranz,et al. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] C. Rose,et al. K+-induced reversal of astrocyte glutamate uptake is limited by compensatory changes in intracellular Na+ , 1999, Neuroscience.
[36] D. Attwell,et al. Glutamatergic signaling in the brain's white matter , 2009, Neuroscience.
[37] A. Pérez-Samartín,et al. The link between excitotoxic oligodendroglial death and demyelinating diseases , 2001, Trends in Neurosciences.
[38] F. Tempia,et al. The GPR17 receptor in NG2 expressing cells: Focus on in vivocell maturation and participation in acute trauma and chronic damage , 2011, Glia.
[39] R. Fields,et al. Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials. , 2002, Neuron.
[40] Carlos Matute,et al. Calcium dyshomeostasis in white matter pathology. , 2010, Cell calcium.
[41] Pamela L. Follett,et al. Glutamate Receptor-Mediated Oligodendrocyte Toxicity in Periventricular Leukomalacia: A Protective Role for Topiramate , 2004, The Journal of Neuroscience.
[42] F. Helmchen,et al. Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo , 2005, Science.
[43] a.R.V.. Neuroglia , 1956, Neurology.
[44] W. Deng,et al. Axon–glia synapses are highly vulnerable to white matter injury in the developing brain , 2012, Journal of neuroscience research.
[45] G. Krissansen,et al. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. , 2004, Brain : a journal of neurology.
[46] G. Mealing,et al. Novel Injury Mechanism in Anoxia and Trauma of Spinal Cord White Matter: Glutamate Release via Reverse Na+-dependent Glutamate Transport , 1999, The Journal of Neuroscience.
[47] R. Fields,et al. Nonsynaptic and nonvesicular ATP release from neurons and relevance to neuron-glia signaling. , 2011, Seminars in cell & developmental biology.
[48] C. Matute,et al. Neuroglial interactions mediated by purinergic signalling in the pathophysiology of CNS disorders. , 2011, Seminars in cell & developmental biology.
[49] P. Stys. White matter injury mechanisms. , 2004, Current molecular medicine.
[50] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[51] S. Richard,et al. Effects of the Noradrenergic System in Rat White Matter Exposed to Oxygen–Glucose Deprivation In Vitro , 2009, The Journal of Neuroscience.
[52] Arcadi Navarro,et al. Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis. , 2009, Archives of neurology.
[53] D. Pitt,et al. Glutamate uptake by oligodendrocytes , 2003, Neurology.
[54] H. Kinney,et al. Diffuse Axonal Injury in Periventricular Leukomalacia as Determined by Apoptotic Marker Fractin , 2008, Pediatric Research.
[55] Paul M Matthews,et al. Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. , 2010, Brain : a journal of neurology.
[56] Todd A Fiacco,et al. Supporting Online Material Materials and Methods Som Text Figs. S1 to S4 Hippocampal Short-and Long-term Plasticity Are Not Modulated by Astrocyte Ca 2+ Signaling , 2022 .
[57] Qi-yue Deng,et al. Downregulation of P2X7 receptor expression in rat oligodendrocyte precursor cells after hypoxia ischemia , 2009, Glia.
[58] V. Gallo,et al. The curious case of NG2 cells: transient trend or game changer? , 2010, ASN neuro.
[59] Pamela L. Follett,et al. Developmental regulation of α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex , 2006, The Journal of comparative neurology.
[60] S. Goldman,et al. P2X7 receptor inhibition improves recovery after spinal cord injury , 2004, Nature Medicine.
[61] T. Möller,et al. Rapid Ischemic Cell Death in Immature Oligodendrocytes: A Fatal Glutamate Release Feedback Loop , 2000, The Journal of Neuroscience.
[62] S. Rivkees,et al. Evidence for physiologically active axonal adenosine receptors in the rat corpus callosum , 1998, Brain Research.
[63] Pamela L. Follett,et al. Developmental regulation of α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex , 2006, The Journal of comparative neurology.
[64] B. Fredholm,et al. Adenosine signaling and function in glial cells , 2010, Cell Death and Differentiation.
[65] Daniel Pelletier,et al. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. , 2005, Brain : a journal of neurology.
[66] B. Ransom,et al. White Matter Vulnerability to Ischemic Injury Increases with Age Because of Enhanced Excitotoxicity , 2008, The Journal of Neuroscience.
[67] Dirk Dietrich,et al. The Fate of Synaptic Input to NG2 Glial Cells: Neurons Specifically Downregulate Transmitter Release onto Differentiating Oligodendroglial Cells , 2010, The Journal of Neuroscience.
[68] G. Burnstock,et al. Purinoceptors on Neuroglia , 2009, Molecular Neurobiology.
[69] F. Pedata,et al. Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia. , 2009, Brain : a journal of neurology.
[70] D. Pitt,et al. Glutamate excitotoxicity in a model of multiple sclerosis , 2000, Nature Medicine.
[71] L. de Haan,et al. Diffusion tensor imaging in the early phase of schizophrenia: what have we learned? , 2010, Journal of psychiatric research.
[72] F. Jensen,et al. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[73] Peter K Stys,et al. Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors , 2009, Annals of neurology.
[74] P. Stys. The axo-myelinic synapse , 2011, Trends in Neurosciences.
[75] M Alda,et al. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. , 2003, Pharmacopsychiatry.
[76] Philip D. Harvey,et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.
[77] C. Matute,et al. System xc− and Glutamate Transporter Inhibition Mediates Microglial Toxicity to Oligodendrocytes1 , 2007, The Journal of Immunology.
[78] C. Matute,et al. Glutamate and Atp Signalling in White Matter Pathology , 2022 .
[79] C. Matute,et al. Intracellular Ca2+ release through ryanodine receptors contributes to AMPA receptor-mediated mitochondrial dysfunction and ER stress in oligodendrocytes , 2010, Cell Death and Disease.
[80] L. Turski,et al. Autoimmune encephalomyelitis ameliorated by AMPA antagonists , 2000, Nature Medicine.
[81] Roger J. Thompson,et al. Ischemia Opens Neuronal Gap Junction Hemichannels , 2006, Science.
[82] A. Verkhratsky. Physiology of neuronal–glial networking , 2010, Neurochemistry International.
[83] G. Burnstock,et al. Purinoceptors on Neuroglia , 2009, Molecular Neurobiology.
[84] G. Perea,et al. GLIA modulates synaptic transmission , 2010, Brain Research Reviews.
[85] G. Burnstock,et al. Purinergic signalling in neuron–glia interactions , 2006, Nature Reviews Neuroscience.
[86] J. Volpe. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances , 2009, The Lancet Neurology.
[87] L. Bronge,et al. Magnetic resonance imaging in dementia: a study of brain white matter changes , 2002 .
[88] M. Salter,et al. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury , 2005, Nature.
[89] A. Pérez-Samartín,et al. P2X7 receptors mediate ischemic damage to oligodendrocytes , 2009, Glia.
[90] Mark Taylor,et al. Glia as transmitter sources and sensors in health and disease , 2010, Neurochemistry International.
[91] B. Ransom,et al. New light on white matter. , 2003, Stroke.
[92] A. Pérez-Samartín,et al. Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition , 2005, Glia.
[93] J. Watters,et al. Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation. , 2010, Recent patents on CNS drug discovery.
[94] A. Pérez-Samartín,et al. Activation of Kainate Receptors Sensitizes Oligodendrocytes to Complement Attack , 2006, The Journal of Neuroscience.
[95] G. Burnstock,et al. Purinergic signalling: From normal behaviour to pathological brain function , 2011, Progress in Neurobiology.
[96] Dwight E Bergles,et al. Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus , 2004, Nature Neuroscience.
[97] Shuxin Li,et al. Mechanisms of Ionotropic Glutamate Receptor-Mediated Excitotoxicity in Isolated Spinal Cord White Matter , 2000, The Journal of Neuroscience.
[98] S. Rivkees,et al. Emerging concepts in periventricular white matter injury. , 2004, Seminars in perinatology.
[99] M. Mattson,et al. Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice , 2007, NeuroMolecular Medicine.
[100] A. Butt. ATP: a ubiquitous gliotransmitter integrating neuron-glial networks. , 2011, Seminars in cell & developmental biology.
[101] M. Barnett,et al. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.
[102] A. Pérez-Samartín,et al. Excitotoxic damage to white matter , 2007, Journal of anatomy.
[103] S G Waxman,et al. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[104] B. Fredholm,et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.
[105] S G Waxman,et al. Modulation of anoxic injury in CNS white matter by adenosine and interaction between adenosine and GABA. , 1994, Journal of neurophysiology.
[106] K. Misulis,et al. DEMYELINATING diseases. , 1952, Lancet.
[107] R. Ravid,et al. Increased expression and function of glutamate transporters in multiple sclerosis , 2006, Neurobiology of Disease.
[108] J. Sepulcre,et al. Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis , 2008, Journal of Neuroimmunology.
[109] L. Steinman,et al. Diverse Targets for Intervention during Inflammatory and Neurodegenerative Phases of Multiple Sclerosis , 2003, Neuron.
[110] N. Danbolt. Glutamate uptake , 2001, Progress in Neurobiology.
[111] R. Fern,et al. Conduction block and glial injury induced in developing central white matter by glycine, GABA, noradrenalin, or nicotine, studied in isolated neonatal rat optic nerve , 2009, Glia.
[112] Pietro Mazzoni,et al. The Behavioral Neurology of White Matter , 2003 .
[113] D. Bergles,et al. Vesicular release of glutamate from unmyelinated axons in white matter , 2007, Nature Neuroscience.
[114] Peter K. Stys,et al. General mechanisms of axonal damage and its prevention , 2005, Journal of the Neurological Sciences.
[115] A. Butt,et al. P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system. , 2002, European journal of pharmacology.
[116] R. J. Dumont,et al. Acute Spinal Cord Injury, Part I: Pathophysiologic Mechanisms , 2001, Clinical neuropharmacology.
[117] N. Dale,et al. Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus1 , 2007, Journal of neurochemistry.
[118] S. Kirischuk,et al. Activation of P2‐purinoreceptors triggered Ca2+ release from InsP3‐sensitive internal stores in mammalian oligodendrocytes. , 1995, The Journal of physiology.
[119] F. Jensen,et al. NMDA Receptor Blockade with Memantine Attenuates White Matter Injury in a Rat Model of Periventricular Leukomalacia , 2008, The Journal of Neuroscience.
[120] R. Swanson,et al. Astrocyte glutamate transport: Review of properties, regulation, and physiological functions , 2000, Glia.
[121] J. Alberch,et al. Bax and Calpain Mediate Excitotoxic Oligodendrocyte Death Induced by Activation of Both AMPA and Kainate Receptors , 2011, The Journal of Neuroscience.
[122] T. Sejnowski,et al. A universal scaling law between gray matter and white matter of cerebral cortex. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[123] J. Meldolesi,et al. Astrocytes, from brain glue to communication elements: the revolution continues , 2005, Nature Reviews Neuroscience.
[124] M. Goldberg,et al. Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes , 2001, The Journal of Neuroscience.
[125] J. Garcìa,et al. Cerebral white matter is highly vulnerable to ischemia. , 1996, Stroke.
[126] B. Fredholm,et al. A1 adenosine receptors mediate hypoxia-induced ventriculomegaly , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[127] P. Somogyi,et al. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus , 2000, Nature.
[128] T. Takano,et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury , 2009, Proceedings of the National Academy of Sciences.
[129] Eve C. Johnstone,et al. White Matter Density in Patients with Schizophrenia, Bipolar Disorder and Their Unaffected Relatives , 2005, Biological Psychiatry.
[130] Mark E. Bastin,et al. White Matter Tractography in Bipolar Disorder and Schizophrenia , 2008, Biological Psychiatry.
[131] D. Attwell,et al. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia , 2005, Nature.
[132] Norio Matsuki,et al. Action-Potential Modulation During Axonal Conduction , 2011, Science.
[133] B. Trapp,et al. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia , 2006, Nature.